Therapeutic Asset Ratings
9,928 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Anaplastic Large Cell Lymphoma
Medical College of Wisconsin
P1
CC
(43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disease
Medical College of Wisconsin
P1
CC
(43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Primary Cutaneous Anaplastic Large Cell Lymphoma
Medical College of Wisconsin
P1
CC
(43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Diffuse Large B-Cell Lymphoma
Medical College of Wisconsin
P1
CC
(43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Hodgkins Lymphoma
Medical College of Wisconsin
P1
CC
(43)
Anti-Cd33 Car T-Cells
Hematopoietic And Lymphoid Cell Neoplasm
iCell Gene Therapeutics
P1
CC
(43)
Anti-Cd5 Car Nk Cells
T Lymphoblastic Leukemia/Lymphoma
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
Anti-Cea Car-T Cells
Liver Cancer
Changhai Hospital
P1
CC
(43)
Anti-Cll-1 Car Nk Cells
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
P1
CC
(43)
Anti-EGFR Antibody-drug Conjugate MRG003
Atypical Teratoid Rhabdoid Tumor
Sun Yat-sen University
P1
CC
(43)
Anti-EGFR Antibody-drug Conjugate MRG003
Diffuse Intrinsic Pontine Glioma
Sun Yat-sen University
P1
CC
(43)
Anti-EGFR Antibody-drug Conjugate MRG003
Head And Neck Squamous Cell Carcinoma
Sun Yat-sen University
P1
CC
(43)
Anti-EGFR Antibody-drug Conjugate MRG003
Nasopharyngeal Type Undifferentiated Carcinoma
Sun Yat-sen University
P1
CC
(43)
Anti-EGFR Antibody-drug Conjugate MRG003
Medulloblastoma
Sun Yat-sen University
P1
CC
(43)
Anti-EGFR Antibody-drug Conjugate MRG003
Childhood Malignant Neoplasm
Sun Yat-sen University
P1
CC
(43)
Anti-EGFR Antibody-drug Conjugate MRG003
Wilms Tumor
Sun Yat-sen University
P1
CC
(43)
Anti-Flt3 Car-T Cells
Acute Myeloid Leukemia
Hemogenyx Pharmaceuticals LLC
P1
CC
(43)
Antigen-Specific Igt Cells
Brain Glioblastoma
Shenzhen Geno-Immune Medical Institute
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Angioimmunoblastic T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Follicular Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Anti-Icos Monoclonal Antibody Medi-570
Mycosis Fungoides
National Cancer Institute (NCI)
P1
CC
(43)
Anti-IL13Ralpha2 CAR T-cells
Astrocytoma, IDH-Mutant, Grade 4
City of Hope Medical Center
P1
CC
(43)
Anti-IL13Ralpha2 CAR T-cells
IDH-Wildtype Glioblastoma
City of Hope Medical Center
P1
CC
(43)
Showing 926 to 950 of 9,928 assets
Previous
Page 38 of 398
Next